Wells Fargo Upgrades Viridian Therapeutic (VRDN) to Overweight
Tweet
Share
E-mail
Get Alerts VRDN Hot Sheet
Price: $23.65 +3.18%
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Join SI Premium – FREE
Wells Fargo analyst Derek Archila upgraded Viridian Therapeutic (NASDAQ: VRDN) from Equal Weight to Overweight with a price target of $31.00.
For an analyst ratings summary and ratings history on Viridian Therapeutic click here. For more ratings news on Viridian Therapeutic click here.
Shares of Viridian Therapeutic closed at $17.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: We Make A Market Buying Older Bonds
- EU And Canada Plan Far-reaching Deal To Strengthen Partnership - Bloomberg
- Accountability Research Downgrades salesforce.com (CRM) to Hold
Create E-mail Alert Related Categories
UpgradesRelated Entities
Wells Fargo, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
